Versican, a proteoglycan recently implicated in hair follicle induction, has been shown to in¯uence axon outgrowth in vitro and in vivo. We used immunohistochemistry to study the relationship between versican expression and innervation, during rat vibrissa follicle development and the adult hair cycle. During development, nerve ®bres were commonly associated with areas of weak versican expression, and the path of axons appeared to be delineated by sharp boundaries of versican expression. Versican expression changed in the lower follicle dermis during the adult hair follicle cycle but remained strong around the follicle neck re¯ecting the constant innervation. Our observations show a correlation between versican expression and peripheral innervation indicating that versican may have a dual role in hair follicle biology. q
Versican, a large extracellular matrix molecule from the aggrecan family of chondroitin sulphate proteoglycans (Schwartz et al., 1999) , has recently been linked to hair follicle induction (Kishimoto et al., 1999) . In the adult hair follicle dermal papilla, versican expression changes with the follicle growth cycle (du Cros et al., 1995) . Versican-like molecules have also been proposed to in¯uence axon growth in vivo and in vitro (Margolis and Margolis, 1997; Yamada et al., 1997; Landolt et al., 1995; Friedlander et al., 1994) and intriguingly, both versican expression and innervation change in the neck of cycling adult pelage follicles (du Cros et al., 1995; Botchkarev et al., 1997) . The innervation of the developed vibrissa follicle has been described in detail (Rice et al., 1986 (Rice et al., , 1993 Fundin et al., 1999) . However, apart from Van Exan and Hardy's study (1980) on the early stages of murine vibrissa follicle innervation, relatively little has been published regarding extracellular molecules associated with follicle innervation.
We have used immunohistochemistry to investigate versican and neuro®lament expression during development and the adult cycle of the rat vibrissa follicle. In both cases spatial and temporal changes in versican expression correlate with follicle innervation.
Results
Versican expression in the mystacial pad changed as vibrissa follicles developed (Fig. 1) . In early development (stage 1±2) versican immunolabelling was signi®cantly weaker in the follicle dermis compared with the surrounding facial dermis (Fig. 2B,C) . At stage 3 the presumptive papilla began to express versican ( Fig. 2E ) and by stage 4/5 the dermal papilla and lower dermal sheath showed strong versican expression, as did a shallow strip of sub-epidermal dermis (Fig. 2F ). Versican expression in the adult vibrissa follicle dermal papilla changed signi®cantly during the hair follicle cycle (Fig. 2G±I) . Versican staining in the anagen dermal sheath diminished slightly in catagen and increased in the thickened dermal sheath of the telogen follicle (Fig.  2G±I) .
The main nerve supply to the follicle primordium (stage 1) approached from the posterior aspect and branched in the dermis beneath the epidermal placode (Fig. 3A,E) . By stage 2 ®bres had diverged around the dermal condensation below the developing follicle bud (Fig. 3B,F) . Staining of adjacent sections revealed that nerves branched within the follicular dermis displaying the weakest versican staining, but interestingly nerves skirted around the dermal condensation itself (Fig. 3B,F) . As follicles elongated and versican staining became evident in the presumptive papilla (stage 3), nerve ®bres became associated with the follicle above the developing papilla (Fig. 3C, G and D, H) . Double-immunolabelling con®rmed that neuro®lament staining patterns coincided with de®ned versican expression patterns (Fig. 4) . Early in development, restricted areas of strong versican labelling correlated inversely with the pattern of innervation (Fig. 4A) . Similarly in the E18 follicle, nerves in the lower part of the follicle were present in areas with weak versican staining. In the upper part of the follicle, the level at which the deep vibrissal nerve ®bres stopped corresponded with the point at which versican labelling started (Fig. 4B) . Small ®bres from super®cial vibrissal innervation were present around the neck of the developed follicle within an area rich in versican (Fig. 4C) .
Immunostaining of E18 and newborn sections (stage 61 follicles) was consistent with the observation that the deep vibrissal nerve approached the follicle from the posterior aspect (Fig. 4D±F ). In the sub-follicular dermis, virtual absence of versican staining corresponded with the path of large nerves (Fig. 4D±F) . In summary, at key points in development, staining of adjacent sections with versican and NF68 antibodies, combined with double immunolabelling, clearly demonstrated that the developing innervation of rat vibrissa follicles was associated with a continually changing versican expression pattern.
Innervation of adult vibrissa follicles remained constant throughout the hair cycle. In anagen, catagen and telogen, branches of the deep vibrissal nerve terminated below the isthmus where endings penetrated the glassy membrane (data not shown). Smaller super®cial vibrissal nerves were omnipresent around the follicle neck (Fig. 5A±C) where versican was abundant (Fig. 5D±F) . Therefore in the neck of vibrissa follicles, constant versican expression correlates with stable innervation, while in the same region of pelage follicles a cyclic decrease in versican expression is accompanied by an increase in innervation (du Cros et al., 1995; Botchkarev et al., 1997) . Taken as a whole these observa- Fig. 2 . Versican expression from stage 1 of development through to the adult vibrissa follicle cycle. Sections of embryonic (A±E, E15; F, E16) and adult (G±I) vibrissa follicles stained with Weigert's haematoxylin, Curtis' ponceau S and Alcian blue (A,D) or immunostained for versican (B,C,E±I). The nerve (arrow) approaches the follicle from the posterior aspect (A) and divides below the developing hair peg sending branches around the sides of the mesenchymal condensation (arrows) (D). Comparable samples show the mesenchymal condensation to be very weakly stained for versican relative to the surrounding dermis (B,C). Dermis around the epidermal downgrowth maintains this weak staining as cells at the base of the hair peg start to develop versican immunoreactivity (E). At a later stage the presumptive papilla and dermal sheath show strong versican labelling (F). Versican is abundant in the dermal papilla in anagen (G), starts to diminish in catagen (H) and is lost in telogen (I). Scale bar, 50 mm (A±F); 100 mm (G±I). (61) neuro®lament staining stops at the border of versican expression (C). (D±F) Demonstrate the overall arrangement of nerve ®bres within a row of vibrissa follicles. The ®bres of the deep vibrissal nerve approach the follicle from the posterior aspect (arrowhead) and wrap around the follicle appearing more distal to the follicle bulb on the rostral aspect than the caudal aspect of the follicle (indicated by lines) (F). Also visible are skin nerves (arrow) that run between the vibrissal follicles and branch to form the super®cial vibrissal nerves (Rice et al., 1986) . Scale bar, 50 mm (A,C); 100 mm (B,D±F). tions suggest a link between versican expression and innervation both in embryonic and adult skin.
Experimental procedures
Vibrissa follicles, isolated from PVG rats as previously described (Robinson et al., 1997) , were sorted according to their hair cycle stage (Williams et al., 1994) . Snouts were dissected from embryonic (E14±E18) and newborn (P0) Wistar rats. Specimens embedded in TissueTek O.C.T. compound (Agar Aids) were snap frozen in liquid nitrogen and stored at 2808C. Some embryonic specimens were ®xed in formal saline and processed for routine wax histology.
Cryosections (7 mm) thaw-mounted on poly-lysine coated slides were air-dried, washed with PBS, incubated with primary antibody diluted in PBS (a -versican, Asher et al. (1991) ), 1:5, DSHB; NF68, 1:100, Sigma; NF200, 1:100, Sigma), washed again with PBS, then incubated with¯uor-escent secondary antibody diluted in PBS (rabbit a -mouse FITC, 1:30, DAKO, with Evans blue counterstain (30 mg/ ml); AlexaFluor 546 a -mouse, 1:200, Molecular Probes; biotinylated goat a -mouse, 1:80, Gibco; TRITC goat arabbit, 1:100, KPL), and washed again with PBS before being mounted under coverslips in mowiol (Calbiochem). Sections treated with biotinylated secondary antibody were incubated with streptavidin FITC (1:80, Gibco) before the ®nal washes with PBS. Negative controls, omitting primary and/or secondary antibody, were performed and the sections incubated in PBS instead. All controls gave negative results. 
